Clinical Trials Browser

Phase 2 × Interventional × Neoadjuvant Therapy \High Risk Prostate Cancer × Clear all

NCT05076851 2021-10-13

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

Phase 2 Unknown

Neoadjuvant Therapy \High Risk Prostate Cancer